| pubmed-article:18347538 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18347538 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:18347538 | lifeskim:mentions | umls-concept:C0042402 | lld:lifeskim |
| pubmed-article:18347538 | lifeskim:mentions | umls-concept:C0277785 | lld:lifeskim |
| pubmed-article:18347538 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18347538 | lifeskim:mentions | umls-concept:C0289313 | lld:lifeskim |
| pubmed-article:18347538 | lifeskim:mentions | umls-concept:C2827654 | lld:lifeskim |
| pubmed-article:18347538 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:18347538 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18347538 | pubmed:dateCreated | 2008-3-18 | lld:pubmed |
| pubmed-article:18347538 | pubmed:abstractText | Transplantation-induced systemic endothelial dysfunction causes severe cardiovascular morbidity and mortality after transplantation. Interventions that improve systemic endothelial function after transplantation and furthermore reduce intragraft vascular dysfunction might improve graft and patient survival. Treatment with the PPARgamma agonist rosiglitazone is an intervention that potentially fulfills these criteria. In this study, we determined the effect of rosiglitazone treatment on transplantation-induced endothelial dysfunction and vasomotor activity in an experimental model for chronic transplant dysfunction in rats. | lld:pubmed |
| pubmed-article:18347538 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18347538 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18347538 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18347538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18347538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18347538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18347538 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18347538 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:18347538 | pubmed:issn | 0041-1337 | lld:pubmed |
| pubmed-article:18347538 | pubmed:author | pubmed-author:NavisGerjanG | lld:pubmed |
| pubmed-article:18347538 | pubmed:author | pubmed-author:RoksAnton J... | lld:pubmed |
| pubmed-article:18347538 | pubmed:author | pubmed-author:HillebrandsJa... | lld:pubmed |
| pubmed-article:18347538 | pubmed:author | pubmed-author:KlatterFlip... | lld:pubmed |
| pubmed-article:18347538 | pubmed:author | pubmed-author:RozingJanJ | lld:pubmed |
| pubmed-article:18347538 | pubmed:author | pubmed-author:OnutaGeaninaG | lld:pubmed |
| pubmed-article:18347538 | pubmed:author | pubmed-author:RienstraHelee... | lld:pubmed |
| pubmed-article:18347538 | pubmed:author | pubmed-author:BoerMark... | lld:pubmed |
| pubmed-article:18347538 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18347538 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:18347538 | pubmed:volume | 85 | lld:pubmed |
| pubmed-article:18347538 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18347538 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18347538 | pubmed:pagination | 582-8 | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:meshHeading | pubmed-meshheading:18347538... | lld:pubmed |
| pubmed-article:18347538 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18347538 | pubmed:articleTitle | Dichotomous effects of rosiglitazone in transplantation-induced systemic vasodilator dysfunction in rats. | lld:pubmed |
| pubmed-article:18347538 | pubmed:affiliation | Department of Cell Biology, Section Immunology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, the Netherlands. | lld:pubmed |
| pubmed-article:18347538 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18347538 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
